Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 26
- Registration Number
- NCT00835354
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Carvedilol 25 mg in 36 Fasted, Healthy, Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT00834795
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Ribavirin 200 mg Tablets Under Fasting Conditions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 28
- Registration Number
- NCT00835146
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00835549
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 100
- Registration Number
- NCT00835588
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00834067
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
🇺🇸Bioassay Laboratory, Inc., Houston, Texas, United States
Leflunomide 20 mg Tablets Under Fasting Conditions
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 84
- Registration Number
- NCT00834418
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00835042
- Locations
- 🇺🇸
Bioassay Laboratory, Inc., Houston, Texas, United States
🇺🇸Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Metformin ER 750 mg Tablets, Fed
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00834613
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Glimepiride 4 mg Tablets Under Non-Fasting Conditions
- Conditions
- Interventions
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 32
- Registration Number
- NCT00835172
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States